• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Don't panic in a down market

Article

The price of a stock I bought last month recently plunged 20 percent. I'm a new investor, and just thinking about this makes me anxious. What should I do?

The price of a stock I bought last month recently plunged 20 percent. I'm a new investor, and just thinking about this makes me anxious. What should I do?

Review your original reasons for buying the stock to see if they still pass muster. Maybe you overlooked a flaw or two that changes your overall assessment of the company's value and potential. If so, admit the goof and cut your loss by selling the stock now; holding on in hopes of an unlikely reversal just gives the problem a chance to compound. But if you still believe the company belongs in your portfolio, seize the opportunity to buy more shares at a bargain price. That's particularly wise if the plunge is due to a setback that's probably temporary, such as a disappointing earnings report or bad news that primarily affects a competitor but is unfairly tainting the entire industry.

Related Videos
Jolie Apicella, JD
David Zetter gives expert advice
David Zetter gives expert advice
Joel Greenwald, MD, CFP
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
Ben Johnston gives expert advice
© 2023 MJH Life Sciences

All rights reserved.